(DMAA - DRUGS MADE IN AMERICA ACQUISITION CORP)

company profile

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Drugs Made In America Acquisition (DMAA) is trading at 10.6

Open Price
10.6
Previous close
10.58
Previous close
10.58
P/E Ratio
48.3326
Shares outstanding
33717143
Primary exchange
NASDAQ-NMS
ISIN
KYG2847J1040